While NanoLogix tried, apparently unsuccessfully,

While NanoLogix tried, apparently unsuccessfully, in 2014 when the Ebola VIRUS hit Africa to find a funding partner for extending their N-Assay capability to the detection of that VIRUS, you sure would think that someone who claims to be an investor would understand that Marburg VIRUS is not the Yersinia Pestis bacteria (Bubonic Plague/ Black Death, etc) and that the tests NanoLogix currently has are for bacteria and not VIRUSES.

Scott